Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2022-06-10 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
北京国枫律师事务所关于中源协和细胞基因工程股份有限公司2022年第二次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of a company's 2022 second extraordinary general meeting of shareholders. It details the legality and validity of the meeting's call, attendance, and voting results. It does not contain financial statements or management discussion but focuses on the procedural and legal aspects of the shareholders' meeting and voting results. This matches the description of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3181 characters, which is consistent with a detailed voting results announcement rather than a full annual or interim report. Therefore, the appropriate classification is DVA.
2022-06-10 Chinese
中源协和细胞基因工程股份有限公司关于归还暂时补充流动资金的闲置募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (492 characters) regarding the return of temporarily used idle raised funds to a special account. It discusses the use and return of idle raised funds for temporary liquidity purposes, referencing a previous board resolution and confirming no impact on the investment projects. There is no detailed financial data or comprehensive report content. The document is an announcement about capital usage and fund management, fitting the category of Capital/Financing Update (CAP).
2022-06-06 Chinese
中源协和细胞基因工程股份有限公司关于召开2022年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2022 second extraordinary general meeting of shareholders for the company 中源协和细胞基因工程股份有限公司. It includes information about the meeting date, voting methods, agenda items, registration procedures, and other logistical details. There is no financial data, audit information, or management discussion of financial results. The document is not a report itself but an announcement related to a shareholder meeting. It does not contain voting results or executive changes, so it is not a Declaration of Voting Results or Board/Management Information. It is a notice about the meeting itself, which fits the category of a Proxy Solicitation & Information Statement (PSI) or possibly an AGM Information (AGM-R). However, since it is a notice about the meeting and agenda rather than materials presented at the AGM, it aligns best with Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains detailed meeting and voting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is PSI with high confidence.
2022-06-06 Chinese
中源协和细胞基因工程股份有限公司2022年第二次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the "2022 Second Extraordinary General Meeting" of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes detailed meeting agenda, voting procedures, and proposed amendments to the company's articles of association. The content is focused on the meeting materials and agenda for a shareholders' meeting rather than the results of voting or a summary of the meeting outcomes. It is not a full annual report, audit report, or earnings release. It is also not a proxy solicitation or voting results announcement. The document is comprehensive and lengthy (15,000 characters), containing detailed meeting materials, which fits the definition of AGM Information (AGM-R).
2022-05-31 Chinese
中源协和细胞基因工程股份有限公司十届十一次临时监事会会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a resolution passed by the company's supervisory board (监事会) regarding the change in the use of raised funds (募集资金) and the permanent supplementation of working capital. It includes details about the meeting, voting results, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial data but rather reports a corporate governance decision related to capital use. It is not an annual or interim report, audit report, or earnings release. It is also not a proxy solicitation or voting results announcement. The content fits best with a Capital/Financing Update (CAP) as it concerns changes in fundraising project allocation and capital structure usage.
2022-05-25 Chinese
中源协和细胞基因工程股份有限公司关于修订公司章程的公告
Governance Information Classification · 95% confidence The document is a detailed announcement about the revision of the company's Articles of Association (公司章程) including specific amendments to various articles, references to compliance with regulatory guidelines such as the "上市公司章程指引" (Listed Company Articles of Association Guidelines) and the Shanghai Stock Exchange listing rules. It includes detailed legal and governance provisions, board and shareholder meeting procedures, and responsibilities of directors and officers. The document states that the amendments will be submitted to the shareholders' meeting for approval. This type of document is a formal announcement of changes to the company's governance documents, specifically the Articles of Association, which falls under Governance Information filings. It is not a full annual report, audit report, or other financial report, nor is it a proxy or voting result announcement. The length and detail confirm it is not a brief notice or a simple announcement but a substantive governance document update.
2022-05-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.